Skip to content

CRISPR THERAPEUTICS AG: filings

Every CRISPR THERAPEUTICS AG annual and quarterly report in the SEC record with the published financial measures it tagged, 40 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-03fiscal Q2 2026451290001193125-26-330672
10-Q2026-05-04fiscal Q1 202645930001193125-26-204188
10-K2026-02-12fiscal FY 2025511330001193125-26-048957
10-Q2025-11-10fiscal Q3 2025451340001193125-25-273337
10-Q2025-08-04fiscal Q2 2025451300000950170-25-102052
10-Q2025-05-06fiscal Q1 202545940000950170-25-064468
10-K2025-02-11fiscal FY 2024511340000950170-25-017899
10-Q2024-11-05fiscal Q3 2024461360000950170-24-121105
10-Q2024-08-05fiscal Q2 2024461320000950170-24-090746
10-Q2024-05-08fiscal Q1 202446960000950170-24-055719
10-K2024-02-21fiscal FY 2023511330000950170-24-017571
10-Q2023-11-06fiscal Q3 2023451330000950170-23-059476
10-Q2023-08-07fiscal Q2 2023441270000950170-23-039075
10-Q2023-05-08fiscal Q1 202343890000950170-23-018811
10-K2023-02-21fiscal FY 2022511330000950170-23-003441
10-Q2022-11-01fiscal Q3 2022461340000950170-22-020845
10-Q2022-08-08fiscal Q2 2022461300000950170-22-015256
10-Q2022-05-09fiscal Q1 202246940000950170-22-008495
10-K2022-02-15fiscal FY 2021511330000950170-22-001282
10-Q2021-11-03fiscal Q3 2021451310000950170-21-002825
10-Q2021-07-29fiscal Q2 2021451270001564590-21-039178
10-Q2021-04-27fiscal Q1 202145920001564590-21-020902
10-K2021-02-16fiscal FY 2020521970001564590-21-006074
10-Q2020-10-28fiscal Q3 2020451310001564590-20-048169
10-Q2020-07-27fiscal Q2 2020411110001564590-20-033602
10-Q2020-04-28fiscal Q1 202041840001564590-20-019278
10-K2020-02-12fiscal FY 2019531960001564590-20-004355
10-Q2019-10-28fiscal Q3 2019501410001564590-19-038024
10-Q2019-07-29fiscal Q2 2019441150001564590-19-026600
10-Q2019-04-29fiscal Q1 201943850001564590-19-013720
10-K2019-02-25fiscal FY 2018491880001564590-19-004115
10-Q2018-11-07fiscal Q3 2018401040001564590-18-028026
10-Q2018-08-07fiscal Q2 2018401040001564590-18-019945
10-Q2018-05-08fiscal Q1 201836740001564590-18-011470
10-K2018-03-08fiscal FY 2017441750001564590-18-004920
10-Q2017-11-08fiscal Q3 2017371010001564590-17-022720
10-Q2017-08-10fiscal Q2 2017361000001193125-17-254536
10-Q2017-05-11fiscal Q1 201735720001193125-17-166631
10-K2017-03-10fiscal FY 2016451540001564590-17-003977
10-Q2016-11-22fiscal Q3 2016381000001193125-16-774104

Inspect the source

Entity
CRISPR THERAPEUTICS AG / CIK 0001674416
Captured
2026-09-21T17:23:00.064Z
SEC response SHA-256
bb57dd5f2b124e21e027bdcf9d925a06e9aa25cb8b2e84515ef679c3b5c3c413

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001674416.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))